RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
134 hedge funds and large institutions have $828M invested in Revance Therapeutics, Inc. in 2019 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 49 increasing their positions, 27 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
21% less call options, than puts
Call options by funds: $1.65M | Put options by funds: $2.08M
Holders
134
Holding in Top 10
2
Calls
$1.65M
Puts
$2.08M
Top Buyers
| 1 | +$22.2M | |
| 2 | +$14.6M | |
| 3 | +$13.6M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$13.3M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
+$12.1M |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$3.54M | |
| 3 | -$3.23M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$2.96M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.15M |